Dose curve [PK / PD]

posted by Sundar.M – India, 2019-02-15 12:37 (545 d 04:50 ago) – Posting: # 19925
Views: 859

Dear all,

How to choose dose for any PK/PD study (without non-clinical data) in healthy volunteer for Phase-1 trials for already marketed product? Other words, how to choose the proposed dose to detect clinically meaningful differences in PK/PD responses?

Thanks for your help.

Thanks
MSMN

Complete thread:

Activity
 Admin contact
21,015 posts in 4,380 threads, 1,460 registered users;
online 33 (0 registered, 33 guests [including 13 identified bots]).
Forum time: Thursday 17:27 UTC (Europe/Vienna)

If you obey all the rules,
you will miss all the fun.    Katharine Hepburn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5